• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA 基因突变的高级别浆液性卵巢癌误诊为子宫内膜囊肿的独特大体形态:病例报告及文献复习。

Misdiagnosis of High-grade Serous Ovarian Cancer With BRCA Mutation as Endometriotic Cyst Due to Its Unique Gross Morphology: A Case Report and Literature Review.

出版信息

Int J Gynecol Pathol. 2021 Mar 1;40(2):165-168. doi: 10.1097/PGP.0000000000000663.

DOI:10.1097/PGP.0000000000000663
PMID:31985581
Abstract

It is believed that high-grade serous ovarian cancer (HGSOC) is a solid or multilocular-solid cancer. Here, we report the case of a 40-yr-old woman with a left ovarian unilocular cyst. Ultrasonography and computed tomographic examination confirmed that the cyst was thin-walled and homogenous in thickness without mural nodules. It was considered to be an endometriotic cyst. Left ovarian cyst excision specimens proved it to be HGSOC after pathologic examination. Therefore, the patient underwent radical surgery for HGSOC. Pathologic examination of radical resection specimens confirmed that the HGSOC was still in FIGO stage IA and no fallopian tube lesion was found. Considering that the patient had a history of breast cancer in both the breasts at a young age, it was hypothesized that the breast cancer susceptibility gene (BRCA) gene may have a germline mutation. Next-generation sequencing confirmed the BRCA1 (c.3770_3771delAG) germline mutation in this patient. Previous studies have reported the special morphological characteristics and growth pattern of HGSOC with BRCA mutation in the advanced stage. Our case demonstrates that HGSOC with the BRCA mutation can also be a unilocular cyst with a thin wall and uniform thickness without a mural nodule, and in the early stage, may have unique gross morphology.

摘要

人们认为高级别浆液性卵巢癌(HGSOC)是一种实性或多房实性肿瘤。在此,我们报告了一例 40 岁女性左侧卵巢单房性囊肿的病例。超声和计算机断层检查证实囊肿壁薄,厚度均匀,无壁结节。考虑为子宫内膜异位囊肿。左卵巢囊肿切除标本经病理检查证实为 HGSOC。因此,患者接受了 HGSOC 的根治性手术。根治性切除标本的病理检查证实 HGSOC 仍处于 FIGO 分期 IA 期,且未发现输卵管病变。鉴于该患者年轻时双侧乳房均患有乳腺癌,推测乳腺癌易感基因(BRCA)基因可能存在种系突变。下一代测序证实了该患者存在 BRCA1(c.3770_3771delAG)种系突变。先前的研究报道了 BRCA 突变的晚期 HGSOC 的特殊形态特征和生长模式。我们的病例表明,携带 BRCA 突变的 HGSOC 也可能是薄壁、均匀厚度且无壁结节的单房性囊肿,且在早期可能具有独特的大体形态。

相似文献

1
Misdiagnosis of High-grade Serous Ovarian Cancer With BRCA Mutation as Endometriotic Cyst Due to Its Unique Gross Morphology: A Case Report and Literature Review.BRCA 基因突变的高级别浆液性卵巢癌误诊为子宫内膜囊肿的独特大体形态:病例报告及文献复习。
Int J Gynecol Pathol. 2021 Mar 1;40(2):165-168. doi: 10.1097/PGP.0000000000000663.
2
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.BRCA 基因突变状态对晚期高级别浆液性卵巢癌生存结局的影响。
J Ovarian Res. 2019 May 7;12(1):40. doi: 10.1186/s13048-019-0511-7.
3
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.高级别浆液性晚期卵巢癌的BRCA突变状态、初始疾病表现及临床结局:一项多中心研究
Am J Obstet Gynecol. 2017 Sep;217(3):334.e1-334.e9. doi: 10.1016/j.ajog.2017.05.036. Epub 2017 May 23.
4
[Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer].[散发性高级别浆液性卵巢癌中BRCA基因突变的临床意义及分布]
Zhonghua Fu Chan Ke Za Zhi. 2017 Jan 25;52(1):26-31. doi: 10.3760/cma.j.issn.0529-567X.2017.01.007.
5
BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study.BRCA 基因突变状态与复发性卵巢癌的个体化管理:一项多中心研究。
Ann Surg Oncol. 2018 Nov;25(12):3701-3708. doi: 10.1245/s10434-018-6700-6. Epub 2018 Aug 20.
6
The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor.卵巢高级别浆液性癌形态学谱的“极左”:一例酷似卵巢浆液性交界性肿瘤的单纯性非浸润性高级别浆液性癌病例报告。
Int J Gynecol Pathol. 2021 Mar 1;40(2):175-179. doi: 10.1097/PGP.0000000000000668.
7
Survival and Chemosensitivity in Advanced High Grade Serous Epithelial Ovarian Cancer Patients with and without a BRCA Germline Mutation: More Evidence for Shifting the Paradigm towards Complete Surgical Cytoreduction.高级别浆液性上皮性卵巢癌患者有无 BRCA 种系突变的生存和化疗敏感性:更多证据表明朝着完全手术细胞减灭术的范式转变。
Medicina (Kaunas). 2022 Nov 8;58(11):1611. doi: 10.3390/medicina58111611.
8
Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer.BRCA1/2 种系和体细胞突变景观在高级别浆液性卵巢癌患者中的分析。
BMC Cancer. 2020 Mar 12;20(1):204. doi: 10.1186/s12885-020-6693-y.
9
Comparison of endometriotic cysts and ovarian cancer in association with endometriotic cysts.子宫内膜异位囊肿与卵巢癌(与子宫内膜异位囊肿相关)的比较。
Cancer Treat Res Commun. 2018;14:26-29. doi: 10.1016/j.ctarc.2017.11.002. Epub 2017 Nov 13.
10
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas.BRCA1 免疫组化在分子特征明确的卵巢高级别浆液性癌队列中的应用。
Am J Surg Pathol. 2013 Jan;37(1):138-46. doi: 10.1097/PAS.0b013e31826cabbd.